Addex Therapeutics (ADXN) Return on Sales (2019 - 2025)
Addex Therapeutics (ADXN) posted Return on Sales of 0.14% for Q4 2025, up 8.4% sequentially from 0.15% in Q3 2025, and down 3.0% YoY from 0.14% in Q4 2024.
Addex Therapeutics (ADXN) Return on Sales (2019 - 2025) Analysis & Trends
Addex Therapeutics has reported Return on Sales for 7 years, with the latest figure at 0.14% in Q4 2025.
- Quarterly Return on Sales fell 3.0% year-over-year to 0.14% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.38% (down 67.0% YoY) and the FY2025 annual result came in at 0.04%, down 26.0% from the prior year.
- Return on Sales improved to 0.14% in Q4 2025 per ADXN's latest filing, from 0.15% in the prior quarter.
- Over five years, Return on Sales peaked at 1.24% in Q2 2024 and troughed at 0.52% in Q4 2023.
- A 5-year average of 0.04% and a median of 0.06% in 2023 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2024 and 2025: Return on Sales jumped 128 bps in 2024, then plunged 132 bps in 2025.
- Over 5 years, Return on Sales stood at 0.01% in 2021, then jumped by 864 bps to 0.11% in 2022, then sank by 590 bps to 0.52% in 2023, then surged by 80 bps to 0.11% in 2024, then plunged by 30 bps to 0.14% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 0.14%, 0.15%, and 0.08% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.14% |
| Sep 30, 2025 | -0.15% |
| Jun 30, 2025 | -0.08% |
| Dec 31, 2024 | -0.11% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 1.24% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | -0.52% |
| Sep 30, 2023 | -0.06% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | 0.11% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.39% |
| Mar 31, 2022 | -0.22% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.05% |
| Jun 30, 2021 | -0.05% |
| Mar 31, 2021 | -0.03% |
| Dec 31, 2020 | -0.01% |